First-Line Antiviral Eye Drops for Herpes Simplex Virus Conjunctivitis
For HSV conjunctivitis, ganciclovir 0.15% gel is the preferred first-line topical antiviral, used 3-5 times daily, as it is less toxic to the ocular surface than trifluridine. 1
Treatment Algorithm
Primary Topical Options
The 2024 AAO Conjunctivitis Preferred Practice Pattern identifies two topical antivirals for HSV conjunctivitis 1:
Ganciclovir 0.15% gel: 3-5 times per day
- Preferred option due to lower ocular surface toxicity 1
- Better tolerated for extended use
Trifluridine 1% solution: 5-8 times per day
- Effective alternative but inevitably causes epithelial toxicity if used >2 weeks 1
- Reserve for cases where ganciclovir is unavailable or ineffective
When to Add Oral Antivirals
Topical antivirals alone may be inadequate for HSV blepharoconjunctivitis—add oral antivirals when there is eyelid involvement 1. Oral options include:
- Acyclovir 200-400 mg five times daily
- Valacyclovir 500 mg 2-3 times daily
- Famciclovir 250 mg twice daily
The combination of topical plus oral therapy has proven effective in preventing progression of HSV blepharoconjunctivitis 1.
Critical Management Points
Avoid Corticosteroids
Never use topical corticosteroids in HSV conjunctivitis—they potentiate HSV epithelial infections 1. This is a critical pitfall that can lead to severe corneal complications.
Follow-Up Timing
Schedule follow-up within 1 week, including:
- Interval history
- Visual acuity measurement
- Slit-lamp biomicroscopy 1
Special Populations
Neonates require immediate pediatrician consultation as systemic HSV infection is life-threatening 1.
Rationale for Ganciclovir Preference
While both ganciclovir and trifluridine demonstrate >90% efficacy for herpetic eye disease 2, ganciclovir's superior safety profile makes it the better first choice. Trifluridine's inevitable epithelial toxicity with prolonged use 1 limits its utility, particularly since HSV conjunctivitis may require extended treatment or recur frequently.
The evidence consistently supports topical antivirals as effective therapy 3, 4, with ganciclovir offering the best balance of efficacy and tolerability for initial management.